Chinese Medicine

  1749-8546

  1749-8546

  Anh Quốc

Cơ quản chủ quản:  BioMed Central Ltd. , BMC

Lĩnh vực:
Complementary and Alternative MedicinePharmacology

Các bài báo tiêu biểu

Chemical markers for the quality control of herbal medicines: an overview
- 2008
Songlin Li, Quan‐Bin Han, Chunxia Qiao, Jing‐Zheng Song, Chuen Lung Cheng, Huan Xu
Abstract

Selection of chemical markers is crucial for the quality control of herbal medicines, including authentication of genuine species, harvesting the best quality raw materials, evaluation of post-harvesting handling, assessment of intermediates and finished products, and detection of harmful or toxic ingredients. Ideal chemical markers should be the therapeutic components of herbal medicines. However, for most herbal medicines, the therapeutic components have not been fully elucidated or easily monitored. Bioactive, characteristic, main, synergistic, correlative, toxic and general components may be selected. This article reviews the effective use of chemical markers in the quality control of herbal medicines including the selection criteria considering the roles and physicochemical factors which may affect the effective use of chemical markers.

Advances in bio-active constituents, pharmacology and clinical applications of rhubarb
Tập 12 Số 1 - 2017
Yujie Cao, Zong‐Jin Pu, Yuping Tang, Juan Shen, Yanyan Chen, An Kang, Guisheng Zhou, Jin‐Ao Duan
Neuroprotective and anti-oxidant effects of caffeic acid isolated from Erigeron annuus leaf
- 2011
Chang‐Ho Jeong, Hee Rok Jeong, Gi Jun Choi, Dae‐Ok Kim, Uk Lee, Ho Jin Heo
Abstract Background

Since oxidative stress has been implicated in a neurodegenerative disease such as Alzheimer's disease (AD), natural antioxidants are promising candidates of chemopreventive agents. This study examines antioxidant and neuronal cell protective effects of various fractions of the methanolic extract of Erigeron annuus leaf and identifies active compounds of the extract.

Methods

Antioxidant activities of the fractions from Erigeron annuus leaf were examined with [2,2-azino-bis(3-ethylbenz thiazoline-6-sulfonic acid diammonium salt)] (ABTS) and ferric reducing antioxidant power (FRAP) assays. Neuroprotective effect of caffeic acid under oxidative stress induced by H2O2 was investigated with [3-(4,5-dimethythiazol-2-yl)-2,5-diphenyl tetrazolium bromide] (MTT) and lactate dehydrogenase (LDH) assays.

Results

This study demonstrated that butanol fraction had the highest antioxidant activity among all solvent fractions from methanolic extract E. annuus leaf. Butanol fraction had the highest total phenolic contents (396.49 mg of GAE/g). Caffeic acid, an isolated active compound from butanol fraction, showed dose-dependent in vitro antioxidant activity. Moreover, neuronal cell protection against oxidative stress induced cytotoxicity was also demonstrated.

Conclusion

Erigeron annuus leaf extracts containing caffeic acid as an active compound have antioxidative and neuroprotective effects on neuronal cells.

Evaluation of the anticancer potential of six herbs against a hepatoma cell line
- 2012
Natthida Weerapreeyakul, Apiyada Nonpunya, Sahapat Barusrux, Thaweesak Thitimetharoch, Bungorn Sripanidkulchai
Corni Fructus: a review of chemical constituents and pharmacological activities
Tập 13 Số 1 - 2018
Yu Dong, Zhe Feng, Hubiao Chen, Fu Sheng Wang, Jiahong Lu
In silico approach in reveal traditional medicine plants pharmacological material basis
- 2018
Fan Yi, Li Li, Lijia Xu, Hong Meng, Yumin Dong, Hai-Bo Liu, Pei‐Gen Xiao
Reflections on treatment of COVID-19 with traditional Chinese medicine
- 2020
Hongyu Luo, Yan Gao, Jian Zou, Siyuan Zhang, Hanbin Chen, Qiao Li, Darren Qiancheng Tan, Yang Han, Yonghua Zhao, Shengpeng Wang
Abstract

Coronavirus disease 2019 (COVID-19) pandemic is spreading rapidly around the globe. By the establishment of an integrative system combining both traditional Chinese medicine (TCM) and western medicine, China has achieved good clinical efficacy in the prevention and control of the pandemic. The advantages of TCM in the treatment of COVID-19 include effective relief of symptoms, retarding the development from mild and moderate to severe, improvement of cure rate, reducing death rates, and promotion of rehabilitation. Besides, according to the different severity levels of individual cases, the National Health Commission of the People’s Republic of China issued treatment guidelines that provide corresponding prescriptions for patients. From the perspective of TCM, this review aims to analyze the role of a variety of TCM prescriptions in the treatment of COVID-19, focusing on the analysis of the “Three TCM prescriptions and three medicines” recommended by the Chinese authorities during the pandemic. We expect that this review will provide insights into the prevention and treatment of COVID-19 with TCM.

The potential insights of Traditional Chinese Medicine on treatment of COVID-19
Tập 15 Số 1 - 2020
Tong Tong, Yingqi Wu, Wei‐Jian Ni, Adong Shen, Sheng Liu
Abstract

Corona Virus Disease 2019 (COVID-19) broke out in 2019 and spread rapidly around the world. There is still no specific antiviral therapy to the current pandemic. In China, historical records show that Traditional Chinese Medicine (TCM) is effective in prevention and enhancing the resistance to pandemic with unique insights. To fight with COVID-19, National Health and Commission of PRC has recommended some TCM in the guideline, such as HuoxiangZhengqi, LianhuaQingwen ShufengJiedu and XueBijing, and actually displayed a remarkable effect in clinical treatment strategic for COVID-19. We review studies to provide an in-depth understanding into the effect of TCM, and also introduce the possible mechanism involved in COVID-19 treatment.

Antioxidant effects of ethyl acetate extract of Desmodium gangeticum root on myocardial ischemia reperfusion injury in rat hearts
Tập 5 Số 1 - Trang 3 - 2010
Gino A. Kurian, Srilalitha Suryanarayanan, Archana Raman, José Padikkala
Flavonoids on diabetic nephropathy: advances and therapeutic opportunities
Tập 16 Số 1 - 2021
Qichao Hu, Caiyan Qu, Xiaolin Xiao, Wenwen Zhang, Yinxiao Jiang, Weihong Zhao, Dan Song, Xi Peng, Xiao Ma, Yanling Zhao
Abstract

With the advances in biomedical technologies, natural products have attracted substantial public attention in the area of drug discovery. Flavonoids are a class of active natural products with a wide range of pharmacological effects that are used for the treatment of several diseases, in particular chronic metabolic diseases. Diabetic nephropathy is a complication of diabetes with a particularly complicated pathological mechanism that affects at least 30% of diabetic patients and represents a great burden on public health. A large number of studies have shown that flavonoids can alleviate diabetic nephropathy. This review systematically summarizes the use of common flavonoids for the treatment of diabetic nephropathy. We found that flavonoids play a therapeutic role in diabetic nephropathy mainly by regulating oxidative stress and inflammation. Nrf-2/GSH, ROS production, HO-1, TGF-β1 and AGEs/RAGE are involved in the process of oxidative stress regulation. Quercetin, apigenin, baicalin, luteolin, hesperidin, genistein, proanthocyanidin and eriodictyol were found to be capable of alleviating oxidative stress related to the aforementioned factors. Regarding inflammatory responses, IL-1, IL-6β, TNF-α, SIRT1, NF-κB, and TGF-β1/smad are thought to be essential. Quercetin, kaempferol, myricetin, rutin, genistein, proanthocyanidin and eriodictyol were confirmed to influence the above targets. As a result, flavonoids promote podocyte autophagy and inhibit the overactivity of RAAS by suppressing the upstream oxidative stress and inflammatory pathways, ultimately alleviating DN. The above results indicate that flavonoids are promising drugs for the treatment of diabetic nephropathy. However, due to deficiencies in the effect of flavonoids on metabolic processes and their lack of structural stability in the body, further research is required to address these issues.